PEG-2 Soyamine

PEG-2 Soyamine and pregnancy

Caution Advised

• Endocrine disruptor
• Absorbed into the body

PEG-2 Soyamine is an emulsifying agent created by combining soybean-derived compounds with polyethylene glycol. It helps mix oil and water ingredients in cleansers, shampoos, and other personal care products to create stable formulations. The ingredient presents two areas of concern during pregnancy. First, it's derived from soy, which contains phytoestrogens that may have weak estrogen-like effects. Second, the ethoxylation process can result in contamination with 1,4-dioxane, a probable carcinogen. While high-quality cosmetic products should have minimal 1,4-dioxane, the potential for exposure combined with hormonal activity from soy compounds creates uncertainty. The enhanced skin permeability that can occur during pregnancy may increase absorption of both the ingredient and any contaminants. While there are no specific regulatory prohibitions on PEG-2 Soyamine during pregnancy, the combination of potential endocrine-disrupting properties and contamination concerns leads many dermatologists and obstetricians to suggest avoiding PEG-soy compounds during pregnancy when safer alternatives are available. The Environmental Working Group rates PEG compounds as moderate hazards due to contamination risks.

PEG-2 Soyamine and breastfeeding

Caution Advised

• Passes into breast milk
• Endocrine disruptor

The concern during breastfeeding relates primarily to the soy-derived phytoestrogens and potential contaminants that could be absorbed through the skin. While topical absorption is limited, PEG compounds can enhance penetration of other ingredients, potentially increasing systemic exposure. Phytoestrogens from soy have been detected in breast milk in mothers consuming soy products, though the amounts from topical exposure would be much lower. The theoretical concern is whether these compounds could affect infant hormone development. Additionally, any 1,4-dioxane contamination that enters the bloodstream could theoretically transfer to breast milk. Most lactation consultants and dermatologists suggest using cleaner emulsifying agents during breastfeeding to minimize any potential infant exposure. Products containing PEG-2 Soyamine are often wash-off formulations, which reduces exposure compared to leave-on products. If you choose to use products with this ingredient, select high-quality brands that test for 1,4-dioxane and avoid applying near the breast area.

PEG-2 Soyamine and postpartum

Safe to Use

• Irritant

For postpartum women who are not breastfeeding, the primary concern with PEG-2 Soyamine is potential skin irritation, which can be more pronounced when skin is sensitive or recovering from pregnancy-related changes. The hormonal concerns are less relevant without infant exposure considerations. Women with sensitive or compromised skin barriers may experience irritation from PEG compounds, particularly in cleansing products where the ingredient is commonly used. Choosing products from reputable manufacturers that test for contaminants minimizes exposure risks. If skin irritation occurs, switching to gentler surfactants is recommended.

PEG-2 Soyamine and trying to conceive

Caution Advised

• Endocrine disruptor

Women trying to conceive are often advised to minimize exposure to potential endocrine disruptors, and the soy-derived phytoestrogens in PEG-2 Soyamine fall into this category. While topical absorption is limited, the precautionary principle suggests avoiding ingredients with any hormone-like activity during the TTC period. Reproductive endocrinologists often recommend that patients trying to conceive adopt pregnancy-safe skincare routines before conception, which would include avoiding PEG-soy compounds. This approach eliminates any theoretical risk during the critical early weeks of pregnancy and optimizes the body's hormonal environment for conception.

PEG-2 Soyamine and PCOS

Caution Advised

• Interferes with hormones
• Irritant

For women with PCOS, the soy-derived phytoestrogens in PEG-2 Soyamine present a theoretical concern. PCOS is a hormonal condition characterized by androgen excess, and introducing compounds with estrogen-like activity, even weak ones from topical sources, may not be ideal for hormonal balance. While the amount of phytoestrogens absorbed from topical products is minimal compared to dietary sources, women with PCOS who are sensitive to hormonal fluctuations may prefer to avoid soy-derived cosmetic ingredients. The irritation potential of PEG compounds may also be problematic for those with PCOS-related inflammatory skin conditions. Many dermatologists specializing in PCOS recommend choosing cosmetic ingredients that don't have any hormone-like activity to avoid any potential interference with treatment or natural hormone regulation. Cleaner surfactants without soy derivatives are widely available and equally effective.

PEG-2 Soyamine and general use

Safe to Use

• Irritant

PEG-2 Soyamine is a functional emulsifying and cleansing agent found in various personal care products. For the general population without hormone-sensitive conditions or pregnancy concerns, it's considered relatively safe when used in properly formulated products from reputable manufacturers. The main concerns for general users are potential skin irritation and the risk of 1,4-dioxane contamination in poorly manufactured products. The EU and US have established limits for 1,4-dioxane in cosmetics, and responsible manufacturers test their products to ensure compliance. Those with sensitive skin may experience irritation from PEG compounds and should watch for reactions. Consumer advocacy groups like the Environmental Working Group suggest choosing products with alternative surfactants when possible, particularly for daily-use items. PEG compounds can compromise the skin barrier with prolonged use in some individuals. However, in properly formulated products used as directed, PEG-2 Soyamine is generally considered acceptable for the healthy general population.

Everything else flagged for the same profiles

• Flagged in pregnancy
• Flagged in breastfeeding
• Flagged in trying to conceive
• Flagged in PCOS

Related ingredients

Ingredients that raise the same concerns.

• ResorcinolEndocrine disruptor, Interferes with hormones, Passes into breast milk
• StyreneEndocrine disruptor, Interferes with hormones, Passes into breast milk
• DEA-Cetyl PhosphateEndocrine disruptor, Interferes with hormones, Passes into breast milk
• Myristamide DipaEndocrine disruptor, Interferes with hormones, Passes into breast milk
• O-PhenylphenolEndocrine disruptor, Interferes with hormones, Passes into breast milk
• Octoxynol-10Endocrine disruptor, Interferes with hormones, Passes into breast milk

Where this came from

Truva summarises published guidance from bodies including ACOG, the FDA, the EU SCCS and the Cosmetic Ingredient Review. It has no access to your medical history and it is not a substitute for your doctor, dermatologist or midwife. These assessments have not been reviewed by a clinician, and nothing here is a diagnosis or a prescription. If you are pregnant, breastfeeding or being treated for PCOS, take the ingredient list to the person looking after you.

Assessment last pulled from the ingredient database on 15 September 2026.